Covestor’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
Covestor's BEAM Position: Q3 2026 in Review
Covestor reduced its Beam Therapeutics (BEAM) stake by 18% in Q3 2026, selling an estimated $11.3K and leaving 1,822 shares worth $45K. The position accounts for 0.03% of the portfolio, ranked #783.
Covestor first reported a position in BEAM in Q4 2021 and has held it in 20 quarters since. The position peaked at $76K in Q2 2026. 191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Covestor held 1,822 shares of Beam Therapeutics worth $45K as of Q3 2026.
- Covestor sold 407 Beam Therapeutics shares in Q3 2026, an estimated $11.3K.
- Beam Therapeutics made up 0.03% of Covestor's portfolio in Q3 2026, its #783 holding.
- Covestor first reported a position in Beam Therapeutics in Q4 2021 and has held it in 20 quarters since.
- Covestor's Beam Therapeutics position peaked at $76K in Q2 2026.
- 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.